patent portfolio overview

Prevention of toxic shock through immunization

  • Single mutant toxin patents
  • Combination vaccine patent¬†
  • RNA vaccine¬†
  • Hyperimmune serum patent 
  • Synthetic antibodies to toxins

Our findings lead to the conclusion that a platform to fight toxins of multiple gram-positive and gram-negative bacteria can be further developed and rolled out. It is not harming any patents of third parties, and it has the full freedom to operate.